Patents by Inventor Damien Michel CRONIER

Damien Michel CRONIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMEN
    Publication number: 20210113692
    Abstract: The invention provides for a dosing regimen for human antibodies that bind to human platelet-derived growth factor receptor alpha (PDGFR alpha), preferably olaratumab.
    Type: Application
    Filed: November 6, 2020
    Publication date: April 22, 2021
    Inventors: John Robert Baldwin, Ilaria Conti, Damien Michel Cronier, Robert Leslie Ilaria, JR., Zhi Lin Mo
  • COMBINATION THERAPY FOR PANCREATIC CANCER
    Publication number: 20200071415
    Abstract: The present invention provides for use in treating and methods of treating pancreatic cancer, in particular, metastatic pancreatic cancer, comprising olaratumab, in combination with gemcitabine and nab-paclitaxel.
    Type: Application
    Filed: March 9, 2018
    Publication date: March 5, 2020
    Inventors: Damien Michel CRONIER, Robert Leslie ILARIA, Jr., Samuel Cowan RAMAGE
  • DOSING REGIMEN
    Publication number: 20170333554
    Abstract: The invention provides for a dosing regimen for human antibodies that bind to human platelet-derived growth factor receptor alpha (PDGFR alpha), preferably olaratumab.
    Type: Application
    Filed: May 9, 2017
    Publication date: November 23, 2017
    Applicant: IMCLONE, LLC
    Inventors: John Robert BALDWIN, Ilaria CONTI, Damien Michel CRONIER, Robert Leslie ILARIA, Jr., Zhi Lin MO